NeurosciencebioRxivPreprint
Deep learning-driven neuromorphogenesis screenings identify repurposable drugs for mitochondrial disease
Carmen Menacho, Satoshi Okawa, Iris Álvarez‐Merz…·Alessandro Prigione
The paper identifies repurposable drugs for mitochondrial disease by using deep learning to screen for compounds that improve neuronal commitment and neurogenesis in Leigh syndrome organoids.